Obesity Trial, Recruiting NCT05974995 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05974995
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a Body Mass Index (BMI) of 30 or higher (considered obese range)
  • People aged 18 or older
  • People who have been diagnosed with a specific type of uterine cancer called endometrioid endometrial cancer, confirmed through a tissue sample test
  • People whose cancer is at an early stage (Stage I), meaning it has not spread beyond the uterus
  • People who are considered medically suitable for keyhole (minimally invasive) surgery
  • People whose overall health status meets a certain surgical fitness level (a standard anaesthetic risk score below 4, confirm with trial site)
  • People who have provided written agreement to participate in the trial

Who may not be able to join:

  • People whose uterus is estimated to weigh more than 250 grams on ultrasound, as this may make keyhole surgery less suitable
  • People who have other pelvic conditions or physical anatomy that may affect the surgery
  • People whose procedure would require use of a uterine manipulator (a tool used during certain gynaecological surgeries) (confirm with trial site)
  • People aged over 75 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francesco Fanfani, MD, Policlinico Gemelli IRCCS

Phone: 0630153421

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Conversion rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov